<乌鸦传媒>Refractory IBD: The Case for Doubling Up on Drugs Meta-analysis suggests select patients can avoid surgery Apr 01, 2021
<乌鸦传媒>JAK Inhibitor Promising in Psoriatic Arthritis Oral agent noninferior to adalimumab in joint symptoms Apr 01, 2021
<乌鸦传媒>Serious Infections Still Common in Vasculitis Cyclophosphamide induction was riskier than rituximab Mar 23, 2021
<乌鸦传媒>What to Tell Patients With Rheumatic/Musculoskeletal Diseases About COVID Vaccines New guidance from the American College of Rheumatology Mar 19, 2021
<乌鸦传媒>Vasculitis Rates Rise With Earth's Latitude Highest rates for giant cell arteritis seen in Scandinavia, lowest in Hong Kong Mar 17, 2021
<乌鸦传媒>Game Changer for Ulcerative Colitis Patients Failing Anti-TNF? JAK inhibitor helped when biologic didn't Mar 12, 2021
<乌鸦传媒>Study Confirms Risk-Adapted CRS Prophylaxis for Acute Leukemia Tocilizumab reduced severe cytokine release syndrome in children, young adults Mar 09, 2021
<乌鸦传媒>Combo Therapy Boosts Response in Uncontrolled Gout "Markedly higher" rate than with pegloticase alone Mar 02, 2021
<乌鸦传媒>Vedolizumab Tied to Lower Risk for Serious Infections in Ulcerative Colitis But positive association versus TNF inhibitors not seen in Crohn's disease Mar 01, 2021
<乌鸦传媒>Anakinra for Gout Flares: Is There a Role? IL-1 blockade was not superior to triamcinolone, but does have advantages Feb 23, 2021
<乌鸦传媒>Lung Hemorrhage in Lupus: Which Patients Die? Risk factors include older age, longer disease duration, infection, and certain treatments Feb 20, 2021
<乌鸦传媒>Avacopan for ANCA Vasculitis: A New Treatment Paradigm? Remission rates not inferior to prednisone -- the "unthinkable" achieved Feb 17, 2021
<乌鸦传媒>Monoclonal Antibody Highly Effective in Phase III Psoriasis Trial Beats ustekinumab, but main side effect was oral candidiasis Feb 05, 2021
<乌鸦传媒>JAK Inhibitor Misses Endpoint in Safety Study. Now What? Major blow to popular class of oral rheumatology drugs Jan 27, 2021
<乌鸦传媒>Colchicine for Early COVID-19? Trial May Support Oral Therapy at Home But some find science-by-press-release troubling Jan 26, 2021
<乌鸦传媒>IBD and COVID: Kids Do Well International registry shows older age, comorbidities are risks; anti-TNF might protect Jan 25, 2021
<乌鸦传媒>Copay Assistance Programs Help Patients but Confuse Them Too Insurers keep track of their use and in some cases won't apply them to patient deductibles Jan 13, 2021
<乌鸦传媒>Staying Safe in Lupus: Monitor Hydroxychloroquine Levels Limit the retinopathy risk while maintaining anti-thrombotic protection, study suggests Jan 11, 2021
<乌鸦传媒>Medicare's 'Most Favored Nation' Drug-Pricing Rule in Limbo Rule affecting Part B drugs was to take effect Jan. 1 but was stopped by federal court orders Jan 07, 2021
<乌鸦传媒>PET Scans Reveal Vascular Inflammation In giant cell arteritis, imaging confirmed clinical response Jan 07, 2021
<乌鸦传媒>Who Flares When SLE Patients Stop Hydroxychloroquine? Flares more likely among minorities, younger patients, and those taking steroids Jan 05, 2021
<乌鸦传媒>Ozanimod a Winner in Ulcerative Colitis S1P receptor modulator effective for both induction and maintenance Dec 10, 2020
<乌鸦传媒>Colchicine Approval Took a Huge Toll on CMS As centuries-old drug is explored for COVID-19, study details the price of approval Nov 30, 2020
<乌鸦传媒>TYK2 Inhibition Promising in Psoriatic Arthritis Phase II study found significant benefits for two doses of novel agent Nov 10, 2020
<乌鸦传媒>More Evidence Early Mortality Persists in IBD Canadian study shows treatment advances haven't erased lifespan deficit Nov 09, 2020
<乌鸦传媒>COVID Complications Common with Rheumatic Disease Adverse outcomes included acute kidney injury and congestive heart failure Nov 08, 2020
<乌鸦传媒>Rinvoq for RA: Benefits Persist Beyond 1 Year Manufacturer's extension study shows no loss of clinical response Nov 06, 2020
<乌鸦传媒>Nonsteroidal Topical, Nanodrug Active in Psoriasis Selected presentations from the European Academy of Dermatology and Venereology meeting Nov 04, 2020
<乌鸦传媒>Upadacitinib, Abatacept Go Head to Head in RA And the winner is... both, depending on whether efficacy or safety is the main criterion Oct 14, 2020
<乌鸦传媒>Depression and Biologic Use in Arthritis: Chicken or Egg? Relationship appears to be bi-directional, researchers say Oct 02, 2020
<乌鸦传媒>Novel Biologic Promising in Mid-Stage Scleroderma Trial Significant differences seen at week 24 for the agent versus placebo on background therapy Sep 28, 2020
<乌鸦传媒>COVID-19 Storms: Bradykinin In, Cytokine Out? Papers poke holes in cytokine storm as gene expression study offers a new theory Sep 11, 2020
<乌鸦传媒>Mepolizumab Offers Relief for Chronic Sinus Trouble Anti-IL5 biologic cut polyp size, need for surgery in chronic rhinosinusitis with nasal polyps Sep 10, 2020
<乌鸦传媒>Capsaicin Injection Improves Knee OA Pain Investigational treatment targets capsaicin receptor to inactivate local pain fibers Sep 06, 2020
<乌鸦传媒>Novel Form of Muscle Relaxant Shows Benefit Tolperisone may help pain from acute back spasms without causing drowsiness Sep 05, 2020
<乌鸦传媒>Joint Effusion Protective in Hand OA Unlike synovitis, which was linked with both pain and progression Sep 03, 2020
<乌鸦传媒>Al Roker's Shoulder Replacement "Today" co-host and weatherman battles osteoarthritis pain Aug 25, 2020
<乌鸦传媒>Lupus Anticoagulant Tied to COVID Thrombosis Small study suggests consideration of therapeutic anticoagulation Aug 12, 2020
<乌鸦传媒>Few Risks for Sjogren's Patients With Joint Surgery Transfusion rates raised but no increase for infection, revision, or mortality Jul 30, 2020
